Market Research Industry Reports

Crinetics Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Crinetics Pharmaceuticals Inc (Crinetics) is a healthcare product provider that discovers and develops drugs for the endocrine disorders. The companys products include neuropeptides and their receptors, orally-available somatostatin agonists, and orally available kisspeptin antagonists. Its neuropeptides controls aspects of human development, physiology and oncogenesis. Crinetics provides somatostatin agonists for the treatment of pancreatic neuroendocrine tumors, carcinoid tumors, GH secreting adenomas, diabetic retinopathy, graves ophthalmopathy, chronic pain, epilepsy, and dementia; and kisspeptin antagonists for the treatment of endometriosis, uterine fibroids, and PCOS. The company has collaboration with National Institute of Health (NIH) and the Ferring research Institute. Crinetics is headquartered in San Diego, California, the US.

Crinetics Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Crinetics Pharma Raises USD63.5 Million in Series B Financing 10
Crinetics Pharma Raises USD60 Million in Venture Financing 12
Crinetics Pharma Raises USD40 Million in Series A Financing Round 13
Crinetics Pharmaceuticals Inc - Key Competitors 14
Crinetics Pharmaceuticals Inc - Key Employees 15
Crinetics Pharmaceuticals Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jan 04, 2018: Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer 17
Government and Public Interest 18
Sep 06, 2017: Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushings Disease 18
Product News 19
07/13/2017: Crinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808 19
03/12/2018: Crinetics Pharmaceuticals Announces Presentation on Hyperinsulinemia Drug Candidate at ENDO 2018 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

List of Tables
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crinetics Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Crinetics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crinetics Pharma Raises USD63.5 Million in Series B Financing 10
Crinetics Pharma Raises USD60 Million in Venture Financing 12
Crinetics Pharma Raises USD40 Million in Series A Financing Round 13
Crinetics Pharmaceuticals Inc, Key Competitors 14
Crinetics Pharmaceuticals Inc, Key Employees 15

List Of Figures

List of Figures
Heska Corp, Performance Chart (2012 - 2016) 25
Heska Corp, Ratio Charts 33

Crinetics Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Crinetics Pharmaceuticals Inc (Crinetics) is a healthcare product provider that discovers and develops drugs for the endocrine disorders. The companys products include neuropeptides and their receptors, orally-available somatostatin agonists, and

USD 250View Report

Crinetics , Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Crinetics , Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review

Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Allena Pharmaceuticals Inc (ALNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme.

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :21
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube